Pfizer’s investigational therapy inclacumab failed to outperform a placebo in reducing vaso-occlusive crises in SCD patients ...

Columnist Oluwatosin Adesoye shares the qualities she looks for in a romantic partner as someone living with sickle cell ...

In her final column, Sylvia Amuta reflects on all she's learned from her experience as a caregiver to her young cousin with ...

People with sickle cell disease may have a higher risk of developing blood cancer, but a lower risk for certain types of ...

Women with SCD have nearly double the rate of acute pain late in pregnancy and right after than in the months following birth ...

The FDA has granted regenerative medicine advanced therapy designation to BEAM-101, a one-time, gene-edited cell therapy for severe SCD.

I’ve shared reflections from three days after my last sickle cell pain crisis, and then again a month later. Now, four months on, I find myself in a completely different place physically, mentally, ...

The FDA has granted regenerative medicine advanced therapy designation to BEAM-101, a one-time, gene-edited cell therapy for severe SCD.

Columnist Tito Oye struggles to describe the pain involved in a sickle cell crisis. She turns to social media to ask her followers for help.

Columnist Tito Oye notes the importance of staying hydrated for those with sickle cell anemia and shares tips on how to maintain sufficient water intake.